Asuragen, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$33Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
17clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Deborah Dillon | Boston, MA | Anatomic Pathology | $5,000.00 |
| Vivianna Van Deerlin | Philadelphia, PA | Clinical Pathology/Laboratory Medicine | $5,000.00 |
| Arielle Medford | Boston, MA | Internal Medicine | $5,000.00 |
| Stirling Puck | Santa Fe, NM | Clinical Genetics (M.D.) | $4,000.00 |
| Tamar Goldwaser | Bronx, NY | Obstetrics & Gynecology | $3,000.00 |
| Annette Kim | Ann Arbor, MI | Clinical Pathology | $3,000.00 |
| Kendal Jensen | San Diego, CA | Anatomic Pathology & Clinical Pathology | $2,750.77 |
| Joseph Willman | Austin, TX | Anatomic Pathology & Clinical Pathology | $2,450.00 |
| Paul Wadsworth | Stanford, CA | $1,701.52 | |
| Sarah Murray | San Diego, CA | Clinical Cytogenetics | $1,122.66 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.